Fulgent Genetics
(NASDAQ) FLGT
Fulgent Genetics Financials at a Glance
Market Cap
$510.00M
Revenue (TTM)
$322.67M
Net Income (TTM)
$60.51M
EPS (TTM)
$-1.97
P/E Ratio
-8.31
Dividend
$0.00
Beta (Volatility)
0.97 (Low)
Dividend
$0.00
Beta (Volatility)
0.97 (Low)
Price
$16.36
Volume
754,138
Open
$16.19
Price
$16.36
Volume
754,138
Open
$16.19
Previous Close
$16.34
Daily Range
$16.09 - $16.44
52-Week Range
$13.46 - $31.04
Dividend
$0.00
Beta (Volatility)
0.97 (Low)
Price
$16.36
Volume
754,138
Open
$16.19
Previous Close
$16.34
Daily Range
$16.09 - $16.44
52-Week Range
$13.46 - $31.04
FLGT News
FLGT: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Fulgent Genetics
Industry
Healthcare Providers and Services
Sector
Health CareEmployees
1,344
CEO
Ming Hsieh
Website
www.fulgentgenetics.comHeadquarters
El Monte, CA 91780, US
FLGT Financials
Key Financial Metrics (TTM)
Gross Margin
41%
Operating Margin
-28%
Net Income Margin
-19%
Return on Equity
-5%
Return on Capital
-8%
Return on Assets
-5%
Earnings Yield
-12.03%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$510.00M
Shares Outstanding
31.23M
Volume
754.14K
Short Interest
0.00%
Avg. Volume
452.10K
Financials (TTM)
Gross Profit
$130.88M
Operating Income
$91.10M
EBITDA
$45.83M
Operating Cash Flow
$101.64M
Capital Expenditure
$22.57M
Free Cash Flow
$124.21M
Cash & ST Invst.
$336.08M
Total Debt
$476.00K
Fulgent Genetics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$83.34M
+9.3%
Gross Profit
$32.58M
+2.3%
Gross Margin
39.10%
N/A
Market Cap
$510.00M
N/A
Market Cap/Employee
$388.42K
N/A
Employees
1,313
N/A
Net Income
$23.42M
-297.7%
EBITDA
$23.03M
-131.6%
Quarterly Fundamentals
Net Cash
$335.60M
+34.4%
Accounts Receivable
$84.76M
+10.0%
Inventory
$0.00
-100.0%
Long Term Debt
$0.00
-100.0%
Short Term Debt
$476.00K
-74.3%
Return on Assets
-4.99%
N/A
Return on Invested Capital
-8.07%
N/A
Free Cash Flow
$83.12M
-491.4%
Operating Cash Flow
$78.14M
-412.3%